跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈

Elsevier
通过我们出版

Profile

Baik-Lin Seong

BS

Baik-Lin Seong

Talk Title: A Novel RNA Vaccine Technology: tRNA-based Protein Vaccines

Yonsei University, Republic of Korea

Talk Title: A Novel RNA Vaccine Technology: tRNA-based Protein Vaccines

Baik-Lin Seong, PhD, is Professor of Yonsei University College of Medicine, and Director General of Vaccine Innovative Technology ALliance (VITAL)-Korea. He served as a member of the Presidential Advisory Council of Science & Technology of Korean Government (2021-2022) and the Scientific Advisory Board of International Vaccine Institute (IVI) (2018-2022). He was the chair of the COVID-19 Vaccine Pan-Government Strategic Plan of Korean Government. With a view to ensure equitable access of effective vaccines to LMICs, he works on developing a low-cost bacterial production of VLP/nanoparticle vaccines against RSV, norovirus, highly pathogenic avian influenza, and flaviviruses including Japanese Encephalitis, Zika, and West Nile viruses